These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20458348)

  • 21. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A; Carruthers J
    Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study.
    Lowe P; Patnaik R; Lowe N
    J Am Acad Dermatol; 2006 Dec; 55(6):975-80. PubMed ID: 17097394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W; Rappl T
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study.
    Lowe PL; Patnaik R; Lowe NJ
    Dermatol Surg; 2005 Dec; 31(12):1651-4. PubMed ID: 16336882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin and wrinkles: few side effects and effective combining procedures with other treatments].
    Ascher B; Rossi B
    Ann Chir Plast Esthet; 2004 Oct; 49(5):537-52. PubMed ID: 15518953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, Patient-Reported Outcomes, and Safety in Male Subjects Treated With OnabotulinumtoxinA for Improvement of Moderate to Severe Horizontal Forehead Lines.
    Keaney TC; Cavallini M; Leys C; Rossi A; Drinkwater A; Manson Brown S; Garcia JK; Mao C
    Dermatol Surg; 2020 Feb; 46(2):229-239. PubMed ID: 31343446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A; Carruthers J; Said S
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies.
    Cavallini M; Cirillo P; Fundarò SP; Quartucci S; Sciuto C; Sito G; Tonini D; Trocchi G; Signorini M
    Dermatol Surg; 2014 May; 40(5):525-36. PubMed ID: 24575858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
    Kaufman-Janette J; Cox SE; Dayan S; Joseph J
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures.
    Fagien S; Carruthers JDA
    Plast Reconstr Surg; 2008 Dec; 122(6):1915-1925. PubMed ID: 19050545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study.
    Ogilvie P; Rivkin AZ; Dayan S; Yoelin SG; Weichman BM; Garcia JK
    Dermatol Surg; 2019 May; 45(5):689-699. PubMed ID: 31034447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of a New Botulinum Toxin (HU-014) Versus Existing Onabotulinumtoxin A in Subjects With Moderate to Severe Glabellar Lines.
    Yoo KH; Lee YW; Lee JS; Kwon SH; Huh CH; Kim BJ
    Dermatol Surg; 2021 Mar; 47(3):e91-e96. PubMed ID: 33481449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
    Kawashima M; Harii K; Horiuchi Y; Seidman E; Lei X; Hopfinger R; Lee E
    Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
    Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
    Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shrink that frown! Botulinum toxin therapy is lifting the face of psychiatry.
    Wollmer MA; Neumann I; Magid M; Kruger TH
    G Ital Dermatol Venereol; 2018 Aug; 153(4):540-548. PubMed ID: 29667799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.